Determinants of prostate cancer-specific survival following radiation therapy for patients with clinically localized prostate cancer

被引：0
|
作者：
D'Amico, AV [1 ]
机构：
[1] Harvard Univ, Sch Med, Joint Ctr Radiat Therapy, Boston, MA 02215 USA
来源：
PROSTATE AND RENAL CANCER, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND BASIC RESEARCH: AND UPDATE | 2003年
关键词：
D O I：
暂无
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：380 / 389
页数：10
相关论文
共 50 条
  • [1] Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer
    D'Amico, AV
    Cote, K
    Loffredo, M
    Renshaw, AA
    Schultz, D
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (23) : 4567 - 4573
  • [2] Predictors of prostate cancer-specific anxiety following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.
    Salari, Kamran
    Aghdam, Nima
    Gersony, Luara
    Danner, Malika
    Ayoob, Marilyn
    Yung, Thomas M.
    Kataria, Shaan
    Lei, Siyuan
    Collins, Brian Timothy
    Kumar, Deepak
    Lischalk, Jonathan W.
    Dritschilo, Anatoly
    Suy, Simeng
    Lynch, John J.
    Collins, Sean P.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [3] OVERALL AND CANCER SPECIFIC SURVIVAL FOLLOWING DEFINITIVE THERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER IN THE PROSTATE-SPECIFIC ANTIGEN ERA
    Stephenson, Andrew
    Klein, Eric
    Ciezki, Jay
    Reddy, Chandana
    Kattan, Michael
    Yu, Changhong
    Deasy, Joseph
    Michalski, Jeff
    Kallogjeri, Donna
    Lubahn, Jessica
    Luly, Jason
    Piccirillo, Jay
    Kibel, Adam
    JOURNAL OF UROLOGY, 2010, 183 (04) : E113 - E113
  • [4] Determinants of prostate cancer specific survival following radiation therapy during the prostate specific antigen era
    D'Amico, AV
    Cote, K
    Loffredo, M
    Renshaw, AA
    Schultz, D
    JOURNAL OF UROLOGY, 2003, 170 (06) : S42 - S46
  • [5] Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era
    D'Amico, AV
    Moul, J
    Carroll, PR
    Sun, L
    Lubeck, D
    Chen, MH
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (11) : 2163 - 2172
  • [6] Radiation therapy for clinically node-positive prostate adenocarcinoma is correlated with improved overall and prostate cancer-specific survival
    Tward, Jonathan D.
    Kokeny, Kristine E.
    Shrieve, Dennis C.
    PRACTICAL RADIATION ONCOLOGY, 2013, 3 (03) : 234 - 240
  • [7] PROSTATE-SPECIFIC ANTIGEN AND RADIATION-THERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER
    ZAGARS, GK
    POLLACK, A
    KAVADI, VS
    VONESCHENBACH, AC
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1995, 32 (02): : 293 - 306
  • [8] Prostate Cancer-Specific Survival in Elderly Patients
    Froehner, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (10) : E281 - E281
  • [9] Bother following stereotactic body radiation therapy for clinically localized prostate cancer
    Bhattasali, Onita
    Chen, Leonard
    Park, Jee-Won
    Kim, Joy S.
    Yung, Thomas M.
    Collins, Brian Timothy
    Suy, Simeng
    Lynch, John
    Dritschilo, Anatoly
    Collins, Sean P.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [10] Survival Among Men With Clinically Localized Prostate Cancer Treated With Radical Prostatectomy or Radiation Therapy in the Prostate Specific Antigen Era
    Kibel, Adam S.
    Ciezki, Jay P.
    Klein, Eric A.
    Reddy, Chandana A.
    Lubahn, Jessica D.
    Haslag-Minoff, Jennifer
    Deasy, Joseph O.
    Michalski, Jeff M.
    Kallogjeri, Dorina
    Piccirillo, Jay F.
    Rabah, Danny M.
    Yu, Changhong
    Kattan, Michael W.
    Stephenson, Andrew J.
    JOURNAL OF UROLOGY, 2012, 187 (04) : 1259 - 1265
12345